Comparing Alendronate vs Boniva
Alendronate | Boniva (ibandronate) |
|
---|
Alendronate | Boniva (ibandronate) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Alendronate helps to reduce the risk of fracture in people with osteoporosis and some other bone conditions. Dosage instructions, including remaining upright for at least 30 minutes and taking with a... View more |
Prescription only
Boniva helps to increase bone mineral density and is given as a tablet once every month or by injection once every three months. Common side effects include gastrointestinal disturbances and back... View more |
Related suggestions Osteoporosis
Prevention of Osteoporosis
|
|||||||
More about Alendronate | More about Boniva (ibandronate) | ||||||||
Ratings & Reviews | |||||||||
Alendronate has an average rating of 2.8 out of 10 from a total of 188 ratings on Drugs.com. 17% of reviewers reported a positive effect, while 78% reported a negative effect. |
Boniva has an average rating of 3.2 out of 10 from a total of 99 ratings on Drugs.com. 17% of reviewers reported a positive effect, while 72% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Alendronate side effects |
View all Boniva side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Lower cost generic |
Lower cost generic approved | ||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Alendronate prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
Binosto, Fosamax |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
N/A |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 118 drugs are known to interact with Alendronate:
|
A total of 178 drugs are known to interact with Boniva:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
September 29, 1995 |
May 16, 2003 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Estrace
Estrace (estradiol) is used to treat symptoms of menopause such as hot flashes and vaginal dryness ...
Atelvia
Atelvia (risedronate) is used to treat osteoporosis in women after menopause. Includes Atelvia side ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Boniva
Boniva (ibandronate) is used to treat or prevent osteoporosis in women after menopause. Includes ...
Risedronate
Risedronate is used for osteoporosis, paget's disease, prevention of osteoporosis
Zoledronic acid
Zoledronic acid is used for hypercalcemia of malignancy, osteolytic bone lesions of multiple ...
Raloxifene
Raloxifene is used for breast cancer, prevention, osteoporosis, prevention of osteoporosis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.